作者：
Joanna,Achinger-Kawecka [1]
;
Clare,Stirzaker [2]
;
Neil,Portman [3]
;
Elyssa,Campbell [4]
;
Kee-Ming,Chia [3]
;
Qian,Du [4]
;
Geraldine,Laven-Law [3]
;
Shalima S,Nair [3]
;
Aliza,Yong [3]
;
Ashleigh,Wilkinson [4]
;
Samuel,Clifton [5]
;
Heloisa H,Milioli [3]
;
Sarah,Alexandrou [3]
;
C Elizabeth,Caldon [3]
;
Jenny,Song [3]
;
Amanda,Khoury [3]
;
Braydon,Meyer [4]
;
Wenhan,Chen [3]
;
Ruth,Pidsley [4]
;
Wenjia,Qu [3]
;
Julia M W,Gee [4]
;
Anthony,Schmitt [3]
;
Emily S,Wong [3]
;
Theresa E,Hickey [4]
;
Elgene,Lim [3]
;
Susan J,Clark [3]
作者单位：
Garvan Institute of Medical Research, Sydney, New South Wales, Australia. j.achinger@garvan.org.au.
[1]
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia. j.achinger@garvan.org.au.
[2]
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
[3]
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.
[4]
Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
[5]
Breast Cancer Molecular Pharmacology Group, School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK.
[6]
Arima Genomics, Inc., Carlsbad, CA, USA.
[7]
Victor Chang Cardiac Institute, Sydney, New South Wales, Australia.
[8]
School of Biotechnology and Biomolecular Sciences, UNSW Sydney, Sydney, New South Wales, Australia.
[9]
Garvan Institute of Medical Research, Sydney, New South Wales, Australia. s.clark@garvan.org.au.
[10]
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia. s.clark@garvan.org.au.
[11]
DOI
10.1038/s41594-023-01181-7
PMID
38182927
发布时间
2024-03-23
换一批
换一批
